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Abstract 
Background: Women in South Africa who use alcohol and other drugs face multiple barriers to HIV care. These barri-
ers make it difficult for women to progress through each step in the HIV treatment cascade from diagnosis to treat-
ment initiation and adherence. This paper examines correlates of HIV status, newly diagnosed HIV status, and use of 
antiretroviral therapy (ART).
Methods: Outreach workers recruited sexually active Black African women who used substances in Pretoria as part 
of a U.S. National Institutes of Health-funded geographically clustered randomized trial examining the effect of an 
intervention to reduce alcohol and drug use as well as sexual risk behaviors. To address the question of interest in the 
current investigation, cross-sectional baseline data were used. At study enrollment, all participants (N = 641) com-
pleted an interview, and underwent rapid HIV testing and biological drug screening. Those who tested positive for HIV 
and were eligible for ART were asked about their barriers to initiating or adhering to ART. Bivariate and multivariable 
logistic regression analyses were conducted to determine correlates of HIV status, newly diagnosed HIV, and ART use.
Results: At enrollment, 55% of participants tested positive for HIV, and 36% of these women were newly diagnosed. 
In multivariable analyses of the entire sample, women who had completed 10th grade were less likely to be living 
with HIV (OR 0.69; CI 0.48, 0.99) and those from the inner city were more likely to be living with HIV (OR 1.83; CI 1.26, 
2.67). Among HIV-positive participants, women were less likely to be newly diagnosed if they had ever been in sub-
stance abuse treatment (OR 0.15; CI 0.03, 0.69) or used a condom at last sex (OR 0.58; CI 0.34, 0.98) and more likely to 
be newly diagnosed if they were physically assaulted in the past year (OR 1.97; CI 1.01, 3.84). Among women eligible 
for ART, fewer were likely to be on treatment (by self-report) if they had a positive urine test for opiates or cocaine (OR 
0.27; CI 0.09, 0.80).
Conclusions: These results, although cross-sectional, provide some guidance for provincial authorities to address 
barriers to HIV care for sexually active, substance-using vulnerable women in Pretoria. Targeting the inner city with 
prevention campaigns, expanding and improving substance abuse treatment programs, linking clients with simulta-
neous HIV testing and treatment, and targeting women who have experienced sexual assault and violence may help 
the government achieve the UNAIDS 90-90-90 treatment target.
Clinical Trials.gov NCT01497405 registered on December 1, 2011.
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Background
Despite progress in reducing HIV incidence, approxi-
mately 2 million people were newly infected worldwide in 
2015 [1]. Biomedical approaches such as HIV treatment 
as prevention offer hope for reducing transmission even 
when condom use is low. In a study of HIV-discordant 
couples, antiretroviral therapy (ART) reduced HIV trans-
mission by 93% [2]. The results of this study combined 
with findings from two ecological studies [3, 4] and sev-
eral modeling studies [5] suggest that high rates of HIV 
testing and treatment could end the HIV epidemic. These 
findings led UNAIDS to establish the “90-90-90” treat-
ment goals whereby 90% of all people infected with HIV 
will know their status, 90% of those diagnosed with HIV 
will receive ART, and 90% of those on ART will achieve 
undetectable HIV viral loads by 2020 [6].
However, achieving the 90-90-90 goals in key popula-
tions, such as people who use drugs, will require inten-
sive efforts to find them, test them for HIV, link them 
to ART, and retain them in treatment [7]. To achieve 
the 90-90-90 goals in a country like South Africa, this 
approach—labeled “seek, test, treat, and retain” (STTR) 
[8]—will require expanding STTR efforts among people 
who use alcohol and other drugs, female sex workers, and 
men who have sex with men [9, 10].
With AIDS being the leading cause of death among 
women of childbearing age globally [11], it is critical to 
increase testing among women at high risk of HIV and 
link those who test positive for HIV to ART. Focusing 
STTR efforts on women in this group has the potential 
to reduce AIDS-related deaths among them. Treating 
HIV-positive women also reduces onward transmission 
of HIV to men who in turn transmit it to other women, 
which is a primary objective of STTR efforts. Moreover, 
treating HIV-positive women may help break the cycle 
in places like sub-Saharan Africa where two-thirds of 
new infections among 15–24-year-olds occurred among 
women in 2015 [1].
Alcohol and other drug use can interfere with STTR 
efforts at each step in the HIV treatment cascade [9]. Use 
of alcohol and other drugs may also reduce pre-exposure 
prophylaxis (PrEP) uptake and adherence [12]. Addi-
tionally, alcohol and other drug use exacerbates existing 
social and structural barriers to HIV testing and HIV-
related services [13] and adversely affects health-seeking 
behavior and health care utilization [14, 15]. In South 
Africa where there are more people living with HIV 
than anywhere else in the world, alcohol and drug use is 
a growing problem, particularly in urban areas. Alcohol 
and marijuana use are most common, although the use 
of heroin, cocaine, Mandrax (methaqualone) and meth-
amphetamine have increased significantly with injecting 
drug use also on the rise [16]. Therefore, it is especially 
pertinent to the South African context to examine both 
alcohol and specific drug use as predictors of progress 
through the HIV treatment cascade. In this paper, we 
hypothesized that recent alcohol and other drug use 
would be negatively associated with forward progress 
through the HIV treatment cascade. More specifically, we 
propose to determine predictors of current HIV status, 
newly diagnosed HIV cases and ART use. Each of these 
stages is important in reaching the 90-90-90 treatment 
goals.
Methods
Procedure overview
The paper presents analyses of cross-sectional baseline 
data collected from women who were recruited by out-
reach workers in Pretoria, South Africa. The complete 
protocol for the study was published in an open-access 
journal [17]. Briefly, the intervention study focuses on 
reducing HIV risk behaviors (e.g., alcohol or drug use, 
unprotected sex) in high-risk women; it also focuses on 
improving adherence to the Test, Treat, and Retain ele-
ments of the HIV cascade for HIV-positive women.
Sample and eligibility
To participate in the study, women had to meet the fol-
lowing eligibility criteria: (1) self-identify as female; (2) be 
Black African; (3) be aged 15 or older (15–17-year-olds 
had to demonstrate tacit emancipation, which shows 
their capacity as a minor to act without parental con-
sent1) [18]; (4) report using alcohol or other drugs at least 
weekly during the past 90  days; (5) report unprotected 
vaginal sex with a male partner in the past 6 months; (6) 
speak English, Sesotho, Tswana, or Zulu; (7) consent to 
HIV rapid testing (blood), drug testing (urine), and alco-
hol breathalyzer; (8) provide written and verbal assent/
consent to participate; and (9) provide verifiable locator 
information for the Pretoria area and plan to stay in the 
area for the next 12 months.
Recruitment
A total of 641 women enrolled in the study between May 
2012 and September 2014. All of the outreach work-
ers for the study were trained on community outreach 
techniques for approaching women in public places and 
1 According to South African law, adolescents under 18, the age of major-
ity, can provide consent unassisted as long as they can provide evidence of 
tacit emancipation. Tacit emancipation occurs when the capacity of a minor 
to act without parental consent is ’enlarged’ to encompass certain key areas 
that will enable him or her to be viewed by the law as a major. The prime 
consideration is the degree of financial independence that the minor has 
achieved. In this respect, ownership of a business or an occupation that 
brings in a salary is key. Residence outside the parental home is regarded as 
further proof of emancipation.
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discreetly screening them for eligibility. Outreach work-
ers received additional training on procedures specific 
to this study such as how to schedule appointments and 
transport women safely to the field site for enrollment 
and data collection. Given the differences in living con-
ditions, access to drugs, and population density across 
the greater Pretoria area, we differentiated where women 
were recruited—either within the inner city (i.e., the Cen-
tral Business District) or outside the inner city. Women 
recruited from the inner-city often spent time in tran-
sient forms of shelter or workplace establishments such 
as abandoned houses or street corners.
Outreach workers conducted eligibility screening and 
scheduled intake appointments for those who were eli-
gible and interested. The appointments, conducted at 
the study’s field site, included the following activities: 
rescreening for eligibility, informed consent, a computer-
assisted personal interview, a finger stick of blood for 
rapid HIV testing, collection of a urine sample for preg-
nancy testing and drug screening, and a breathalyzer 
test for recent alcohol use. Participants received toilet-
ries worth R100 (at the time of the study, $1 US equaled 
approximately 10 South African Rand) for their time and 
reimbursement for travel.
Self‑report measures
The primary data collection instrument—the Pretoria 
Risk Behavior Assessment (PRBA)—included sections on 
sociodemographic characteristics, alcohol and other drug 
use, substance abuse treatment, sexual behavior, violence 
perpetration and victimization, and physical and mental 
health. In a previous study in Pretoria, the PRBA demon-
strated high reliability and validity [19].
Sex risk
Three measures of sex risk were included: the number of 
sex acts (anal and vaginal) without a condom in the past 
30 days; condom use at last sex; and engaging in sex work 
or trading sex for drugs, money, food, clothing, shelter, or 
any other goods in the past 6 months.
Alcohol and other drug use
Measures included use of marijuana, cocaine (includes 
powder cocaine and crack), heroin by itself, and Nyaope 
(heroin mixed with marijuana). For each substance, par-
ticipants were asked if they had ever used it (i.e., lifetime 
use). Participants who reported lifetime use were asked 
the number of days they had used the substance in the 
past 30 days. We recoded these variables into any use of 
each drug in the past 30 days. We used the Alcohol Use 
Disorders Identification Test (AUDIT) to assess problem 
drinking using a cut-point of 20, which indicates probable 
alcohol dependence and a need for alcohol treatment [20].
Victimization
The PRBA included the following ordered items to meas-
ure physical and sexual abuse:
  • Has anyone ever physically hurt you (i.e., someone 
hurt you by striking or beating you to the point that 
you had bruises, cuts, or broken bones)?
•  When was the last time you were physically hurt?
  • Has anyone ever pressured you or forced you to par-
ticipate in sexual acts against your will?
•  When was the last time you were pressured or 
forced to participate in sexual acts against your 
will?
The analyses used derived variables for physical abuse 
and for sexual abuse in the past year.
Mental and physical health
We used the Mental Health scale from Version 2 of the 
SF-36 Health Survey [21] to assess participants’ men-
tal health and the Vitality scale to assess physical health. 
Raw scores were computed and transformed according to 
instructions in the manual. Specifically, scale scores were 
transformed using the following formula: [(Actual raw 
score  −  lowest possible raw score)/(possible raw score 
range)] × 100. Higher scores on the Mental Health and 
Vitality scales are associated with better functioning. Our 
focus in this paper was to identify factors that distinguish 
among women in the sample at each step in the HIV 
treatment cascade. Therefore, we did not compare SF-36 
scale scores in the sample to scores in the broader popu-
lation in South Africa.
Antiretroviral therapy (ART)
To assess current ART status, the questionnaire asked 
participants who reported ever testing positive for HIV 
the following questions: “Have you ever taken any ARV 
medications? Are you taking any ARV medications now?”
Barriers to HIV treatment initiation and retention
We assessed barriers to HIV treatment initiation, reten-
tion in treatment, and adherence to HIV medication with 
the question: “Why have you stopped or not taken ARV 
(anti-HIV) medications, either now or in the past?” A 
list of response options followed the question along with 
instructions to “check all that apply.” Participants also 
had the option to respond “other” and specify an unlisted 
response. The research team collapsed the responses into 
the themes.
Biological tests
Alcohol and other drug use
A breathalyzer was used to assess recent alcohol use. 
Participants provided a urine sample for drug testing. A 
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multipanel drug test was used to assess marijuana (THC), 
cocaine, ecstasy (MDMA), and opiate use (Homemed 
Multi drug 5-Panel Dipcard).
HIV status
All participants were tested for HIV at baseline regard-
less of self-report. Testing was done by collecting a 
blood sample from a finger stick and performing two 
parallel rapid HIV tests (First  Response® HIV 1-2.0 or 
 ABON®-Alere HIV 1/2/O Tri-line HIV Rapid Test and 
iCARE One Step HIV [1&2] Whole Blood/Serum/Plasma 
Test). If one test was positive and the other test was 
either indeterminate or negative, then a confirmatory test 
was performed (Alere Determine™ HIV-1/2). A partici-
pant was classified as HIV positive if any two of the tests 
were reactive.
Housing
We captured differences in level of disadvantage by ask-
ing participants whether they lived in an informal set-
tlement. In South Africa, most informal settlements are 
made up of a collection of shacks that have not been 
formally approved by the government. Some informal 
settlements may exist for years and have hundreds of 
thousands of residents.
Recruitment area
Women were differentiated based on location of recruit-
ment because the city of Pretoria consists of varying lev-
els of disparity. Women were classified as having been 
recruited from the inner city versus outside the inner 
city. The inner city indicates that women were recruited 
from within the Central Business District and often were 
found in transient forms of shelter or near drug-dealing 
establishments such as abandoned houses or high drug 
traffic street corners.
Historical factors
The recruitment period for this study overlapped with the 
South African government’s campaign to increase HIV 
testing and treatment. Therefore, we included month 
of recruitment in our models to assess the campaign’s 
success in reaching our population and as a potential 
confounder.
Statistical analysis
We used multivariable logistic regression analyses to test 
hypotheses regarding associations between independ-
ent variables of interest (e.g., alcohol, drug use, sex work) 
and HIV status, newly diagnosed with HIV, and being 
on ART. The analysis examining correlates of HIV status 
included all women in the study (n = 641). The analysis 
examining correlates of newly diagnosed HIV included 
all HIV-positive women (n  =  354) whereas the analy-
sis examining factors associated with ART use included 
only HIV-positive women who were eligible for ART 
(n =  156). Bivariate analyses examined the associations 
between dependent variables and each covariate. Covari-
ates that were statistically significant at p < .05 in bivari-
ate analysis were included in the multivariable model. 
When two highly correlated independent variables were 
both significantly associated with an outcome in bivariate 
analyses, we included only one of them in the multivari-
able model based on substantive and theoretical consid-
erations. In the ART model, we excluded one variable 
(ever in substance abuse treatment) from the multivari-
able model because of small cell sizes. Analyses were per-
formed in SPSS version 23 (IBM Corp.; Armonk, NY).
Results
Of the 1012 women screened for eligibility, 772 (76%) 
met all of the eligibility criteria. Most (86%) of the women 
who were ineligible did not meet the criterion of self-
reported alcohol or other drug use at least once a week 
over the previous 90  days. Among eligible women, 83% 
(641/772) enrolled into the study. Women who declined 
to participate and those who enrolled into the study were 
similar with respect to age, language, and having a main 
sex partner; 53% of women who declined to participate 
reported sex work compared with 43% of women who 
enrolled in the study (p = .01).
Only three women reported ever injecting illicit drugs. 
Self-reported use of heroin—either alone or mixed with 
marijuana (Nyaope)—and biological test results for opi-
ates were similar (17 vs. 18%, p  >  .05). Slightly more 
women reported marijuana use in the past 30 days than 
had a positive drug screen result (38 vs. 31%, p  >  .05). 
Significantly fewer women reported using cocaine in 
the past 30  days than tested positive for it (12 vs. 14%, 
p  <  .05). However, despite the statistical significance, 
even these results were quite similar.
HIV testing and prevalence (“seek and test”)
During their baseline interview, 90% of the participants 
reported having been tested for HIV previously. At 
enrollment in the study, 55% (n = 354) of women had a 
positive test result for HIV. Table 1 displays characteris-
tics of the participants stratified by HIV status as well as 
results from the bivariate and multivariable analyses. In 
Fig.  1, we present the study participants reached along 
the treatment cascade of seek, test and treat being only 
baseline data. In multivariable analyses, being older, 
engaging in sex work, being recruited in the inner city, 
and living in an informal settlement were associated with 
increased odds of testing positive for HIV, whereas more 
education had a protective effect.
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Newly diagnosed with HIV
Among the 354 women who tested positive for HIV, 36% 
(n = 126) were newly diagnosed. Of these, 27% reported 
never receiving an HIV test. Among those who had 
been tested, the median number of months since their 
most recent HIV test was 23. Table 2 displays the results 
Table 1 Correlates of HIV among high-risk women in Pretoria, South Africa
* p < .05; ** p < .01; *** p < .001
a SF-36 Mental Health and Vitality scales
Transformed scale = [(Actual raw score − lowest possible raw score)/(possible raw score range)] × 100
b The reference group is recruited from outside the inner city
c Century month (CM). January 2001 = 1. The project recruited from May 2012 (CM = 136) to September 2014 (CM = 164). South Africa was in the midst of scaling up 
HIV testing and treatment during this period
d The reference group is not living in an informal settlement
Variable HIV status Bivariate logistic 
regression
Multivariable logistic 
regression
Negative Positive
Sociodemographic characteristic (n = 287) (n = 354) OR (95% CI) OR (95% CI)
Age in years, mean (SD) 29.0 (8.5) 31.5 (7.0) 1.04 (1.02, 1.07)*** 1.03 (1.01, 1.05)**
% education ≥10th grade 70.4 56.5 0.55 (0.39, 0.76)*** 0.69 (0.48, 0.98)*
% unemployed 82.7 87.7 1.49 (0.93, 2.38)
% married or living as married 46.7 52.5 1.26 (0.93, 1.73)
% ever had a family member with HIV/AIDS 59.1 64.9 1.28 (0.93, 1.76)
% ever incarcerated (lifetime) 29.7 39.5 1.55 (1.11, 2.15)** 1.10 (0.76, 1.59)
% ever in substance abuse treatment (lifetime) 7.0 5.6 0.80 (0.42, 1.52)
Urine drug screen and breathalyzer results
% marijuana (THC) positive 31.4 31.4 1.0 (0.71, 1.40)
% opiate positive 19.2 16.9 0.86 (0.57, 1.29)
% cocaine positive 15.7 13.3 0.82 (0.53, 1.28)
% opiate or cocaine positive 21.3 20.3 0.95 (0.64, 1.39)
% alcohol (breathalyzer) positive 12.9 15.3 1.22 (0.77, 1.91)
Mean breathalyzer score for women with a positive alcohol test 
(SD)
0.08 (0.11) 0.08 (0.11) 1.69 (0.03, 82.96)
Self-report alcohol and drug use past 30 days
% alcohol 84.7 88.7 1.42 (0.90, 2.25)
% marijuana 28.6 30.5 1.01 (0.78, 1.55)
% cocaine (rock) 13.2 10.5 0.76 (0.47, 1.24)
% heroin and marijuana mixed (Nyaope) 18.8 15.3 0.78 (0.51, 1.17)
Self-report Alcohol Use Disorders Identification Tests (AUDIT) 
score ≥20
26.5 34.2 1.44 (1.02, 2.03)* 1.43 (0.99, 2.07)
Sex risk behaviors
% used a condom at last sex 28.5 43.3 1.92 (1.37, 2.68)*** 1.45 (0.97, 2.16)
# times unprotected sex past 30 days, mean (SD) 8.6 (12.9) 8.9 (14.2) 1.00 (0.99, 1.01)
Sex work past 6 months 26.8 45.2 2.25 (1.61, 3.14)*** 1.47 (0.98, 2.22)
Victimization
% physically assaulted past year 9.1 13.3 1.54 (0.93, 2.55)
% sexually assaulted past year 5.2 7.3 1.44 (0.75, 2.77)
SF-36 mental health and vitality scales
Mental health scale score, mean (SD)a 65.1 (19.2) 64.3 (19) 1.00 (0.99, 1.01)
Vitality scale score, mean (SD)a 34.2 (18.3) 35.7 (17.2) 1.00 (1.00, 1.01)
Contextual factors
% recruited from inner  cityb 24.4 40.4 2.1 (1.49, 2.96)*** 1.90 (1.30, 2.78)**
Century month  recruitedc, mean (SD) 150.7 (8.5) 150.3 (8.7) 0.99 (0.98, 1.01)
% living in informal  settlementd 30.3 38.4 1.43 (1.03, 2.00)* 1.49 (1.04, 2.14)*
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related to being newly diagnosed with HIV. More specifi-
cally, the multivariable analysis shows that being older, 
having a history of substance abuse treatment, and using 
a condom at last sex were associated with decreased 
odds of being newly diagnosed with HIV, whereas physi-
cal assault in the past 12  months was associated with 
increased odds of being newly diagnosed.
Treat
Among the 228 women who reported during their base-
line interview that they knew they were living with HIV, 
72 of these women reported that they were not eligible 
for ART because their CD4 count was too high. Of the 
156 women who were eligible for ART, 88 (56%) reported 
being on ART. The analyses of factors associated with 
being on ART exclude the 72 women who were not eligi-
ble for it (see Table 3). In multivariable analyses, older age 
and later month enrolled in the project were significantly 
associated with increased odds of being on ART, whereas 
having a positive urine drug screen for either opiates or 
cocaine metabolites was associated with significantly 
decreased odds of being on ART. In additional analyses 
to clarify the association between a history of substance 
abuse treatment and not being on ART, we found that 
80% of women with a history of substance abuse treat-
ment tested positive for opiates or cocaine.
Barriers to treatment initiation and retention
When this study began recruiting, South Africa offered 
ART only to patients whose CD4 cell count was below 
350  cells/ml. By the time recruitment ended, the gov-
ernment had raised the threshold for starting ART to 
500 cells/ml. Tying eligibility for ART to CD4 cell count 
means many women were not eligible for ART.
Among participants who were eligible for ART, the 
primary barriers to ART initiation and retention were 
structural factors such as the clinic not providing ART, 
and individual factors, such as missing appointments 
(Table  4). Personal beliefs and perceived need for ART 
remain problematic.
Discussion
With 55% of the sample testing positive for HIV, this 
study demonstrates the feasibility of using commu-
nity outreach to find (seek) women at high risk for HIV 
and test them. Women’s biological susceptibility [22] 
combined with social determinants such as economic 
dependence and inequitable gender norms contrib-
ute to the high prevalence and incidence of HIV among 
women in developing countries [23, 24]. To prevent new 
infections among women in these settings, STTR efforts 
will need to include the men who are infecting women 
in addition to women. However, the most direct way to 
prevent women in these settings from acquiring HIV may 
be to offer them PrEP [25]. Contrary to our hypothesis, 
there was no relationship between testing positive for 
alcohol or other drugs and testing positive for HIV in this 
sample. This may be due the fact that all women in the 
study had to report use of alcohol and other drugs.
Similar to HIV status, there was no association between 
recent drug and alcohol use and being newly diagnosed 
with HIV in this sample, which may be explained by the 
high rates of HIV testing in the sample. Although 90% of 
the entire sample and 95% of women who tested positive 
for HIV reported a previous HIV test, 36% of women with 
a positive test were unaware of their status. Among the 92 
newly diagnosed women who reported a previous HIV 
test, the median number of months since their most recent 
test was 23. To achieve the goal of 90% of HIV-positive 
women in this population knowing their HIV status, more 
women need to be tested, and they must be tested more 
frequently—preferably at least once a year and more fre-
quently, if symptomatic. Because almost all of these women 
likely acquired HIV through sex with men, increases in HIV 
testing and treatment among women must be accompa-
nied by similar increases among men to reduce incidence. 
Unfortunately, efforts to test and treat Black African men in 
South Africa have been less successful [26, 27].
During their baseline interview, only 56% of the 156 
women who were aware of their HIV status and eligible 
for ART reported receiving it. In the multivariable model, 
the significant association between being recruited later 
in the project and being on ART suggests that the South 
African government’s efforts to increase HIV testing and 
treatment are beginning to work. Nevertheless, much 
more work remains to be done before South Africa will 
achieve the 90-90-90 goals.
SEEK 
641 women enrolled in 
the study 
TEST 
354 women living with 
HIV, 126 newly 
diagnosed; 64% aware
TREAT
88 women currently on 
ART; 56% eligible on 
ART
Fig. 1 HIV cascade for women recruited for the study
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In contrast to the other steps in the HIV cascade, 
recent drug use was associated with not being on ART 
among women who already knew they were living with 
HIV. Women who had a urine drug screen result positive 
for cocaine or opiate metabolites were only about 25% 
as likely to report being on ART compared with women 
who tested negative. This finding is consistent with previ-
ous studies that reported heavy drug use interfered with 
ART initiation and retention [28]. In addition, the associ-
ation between being older and being on ART may be due 
to older women who have been infected longer becoming 
symptomatic, thus leading them to seek treatment.
Findings from this paper highlight the urgent need for 
additional resources to increase access to treatment for 
substance use disorders. Studies have shown that integrat-
ing the continuum of care with substance use and HIV 
treatment programs can decrease alcohol and drug use 
and offer better overall health outcomes among patients 
living with HIV [29, 30]. Providing greater access to treat-
ment for substance use disorders and co-locating health 
departments that offer ART and substance use treatment 
has the potential to increase ART initiation and retention.
In January 2015, South Africa began implementing 
the 2013 World Health Organization recommendation 
Table 2 Correlates of newly diagnosed HIV among HIV-positive women in Pretoria, South Africa
* p < .05; ** p < .01; *** p < .001
a SF-36 Mental Health and Vitality scales
Transformed scale = [(Actual raw score − lowest possible raw score)/(possible raw score range)] × 100
b The reference group is recruited from outside the inner city
c Century month (CM). January 2001 = 1. The project recruited from May 2012 (CM = 136) to September 2014 (CM = 164). South Africa was in the midst of scaling up 
HIV testing and treatment during this period
d The reference group is not living in an informal settlement
Variable Previously 
diagnosed
Newly  
diagnosed
Bivariate logistic 
regression
Multivariable logistic 
regression
Sociodemographic characteristic n = 228 n = 126 OR (95% CI) OR (95% CI)
Age in years, mean (SD) 32.7 (6.9) 29.1 (7.0) 0.92 (0.89, 0.95)*** 0.91 (0.88, 0.95)***
% education ≥10th grade 57.5 54.8 1.11 (0.71, 1.75)
% unemployed 89.1 85.3 0.71 (0.36, 1.41)
% married or living as married 54.4 49.2 0.81 (0.53, 1.26)
% ever had a family member with HIV/AIDS 66.1 62.7 0.86 (0.55, 1.36)
% ever incarcerated (lifetime) 40.8 37.3 0.86 (0.55, 1.35)
% ever in substance abuse treatment (lifetime) 7.9 1.6 0.19 (0.04, 0.82)* 0.15 (0.03, 0.69)*
Urine drug screen and breathalyzer results
% marijuana (THC) positive 33.3 27.8 0.77 (0.48, 1.24)
% opiate positive 17.1 16.7 0.97 (0.54, 1.73)
% cocaine positive 14.0 11.9 0.83 (0.43, 1.6)
% opiate or cocaine positive 20.2 20.6 1.03 (0.60, 1.76)
% alcohol (breathalyzer) positive 16.3 13.5 0.80 (0.43, 1.49)
Sex risk behaviors
% used a condom at last sex 48.9 33.3 0.52 (0.33, 0.82)** 0.58 (0.34, 0.98)**
# times unprotected sex past 30 days, mean (SD) 8.2 (12.9) 10.2 (16.3) 1.01 (0.99, 1.02)
% engaged in sex work past 6 months 50.0 36.5 0.58 (0.37, 0.90)* 0.83 (0.49, 1.40)
Victimization
% physically assaulted past year 10.5 18.3 1.90 (1.02, 3.52)* 1.97 (1.01, 3.84)*
% sexually assaulted past year 6.6 8.7 1.36 (0.60, 3.05)
SF-36 mental health and vitality scales
Mental health scale score, mean (SD)a 58.4 (14.4) 59.0 (15.8) 1.00 (0.99, 1.02)
Vitality scale score, mean (SD)b 36.6 (16.9) 33.9 (17.7) 0.99 (0.98, 1.00)
Contextual factors
% recruited from inner  cityb 40.4 40.5 1.01 (0.65, 1.57)
Century month  recruitedc, mean (SD) 150.3 (8.9) 150.3 (8.4) 1.00 (0.97, 1.02)
% living in informal  settlementd 36.4 42.1 1.27 (0.81, 1.98)
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Table 3 Factors associated with ART use among women who knew they were living with HIV and were eligible for ART
* p < .05; ** p < .01; *** p < .001
a SF-36 Mental Health and Vitality scales
Transformed scale = [(Actual raw score − lowest possible raw score)/(possible raw score range)] × 100
b The reference group is recruited from outside the inner city
c Century month (CM). January 2001 = 1. The project recruited from May 2012 (CM = 136) to September 2014 (CM = 164). South Africa was in the midst of scaling up 
HIV testing and treatment during this period
d The reference group is not living in an informal settlement
Variable Not on ART Currently  
on ART
Bivariate logistic  
regression
Multivariable  
logistic regression
Sociodemographic characteristic n = 68 n = 88 OR (95% CI) OR (95% CI)
Age in years, mean (SD) 30.7 (7.0) 35.9 (6.5) 1.13 (1.07, 1.19)*** 1.08 (1.02, 1.15)**
% education ≥10th grade 60.3 53.4 0.92 (0.48, 1.78)
% unemployed 86.0 86.7 1.07 (0.38, 2.96)
% married or living as married 52.9 60.2 1.35 (0.71, 2.55)
% family member with HIV/AIDS 59.7 79.5 2.62 (1.29, 5.35)** 2.09 (0.90, 4.82)
% ever incarcerated (lifetime) 51.5 28.4 0.37 (0.19, 0.73)**
% ever in substance abuse treatment (lifetime) 16.2 1.1 0.06 (0.01, 0.47)**
Urine drug screen and breathalyzer results
% marijuana (THC) positive 50.0 19.3 0.24 (0.12, 0.49)***
% opiate positive 30.9 4.5 0.11 (0.03, 0.33)***
% cocaine positive 25.0 4.5 0.14 (0.05, 0.45)**
% opiate or cocaine positive 35.3 6.8 0.13 (0.05, 0.35)*** 0.27 (0.09, 0.80)*
% alcohol (breathalyzer) positive 14.7 15.9 1.10 (0.45, 2.65)
Sex risk behaviors
% used a condom at last sex 49.2 39.8 0.68 (0.36, 1.30)
# times unprotected sex past 30 days, mean (SD) 10.3 (18.7) 7.5 (9.4) 0.99 (0.96, 1.01)
% engaged in sex work past 6 months 58.8 38.6 0.44 (0.23, 0.84)*
Victimization
% physically assaulted past year 13.2 8.0 0.57 (0.20, 1.61)
% sexually assaulted past year 11.8 4.5 0.36 (0.10, 1.24)
SF-36 mental health and vitality scales
Mental health scale score, mean (SD)a 56.1 (13.5) 60.6 (14.0) 1.02 (1.00, 1.05)* 1.02 (1.00, 1.04)
Vitality scale score, mean (SD)b 42.2 (18.8) 33.4 (14.4) 0.97 (0.95, 0.99)*
Contextual factors
% recruited from inner  cityb 54.4 26.1 0.30 (0.15, 0.58)***
Century month  recruitedc, mean (SD) 147.0 (8.8) 153.6 (8.3) 1.09 (1.05, 1.13)*** 1.06 (1.01, 1.11)*
% living in informal  settlementd 32.4 38.6 1.32 (0.68, 2.56)
Table 4 Barriers to obtaining or adhering to ART
a Not mutually exclusive
Theme Specific  itemsa N %
Missed appointments Missed staging appointment, did not attend wellness appointment 24 35.3
Structural factors Change in clinic, clinic not providing ART, lack of transportation, no identification card, no 
food, no place to store pills
23 33.8
Personal beliefs about ART and own readiness Fear of side effects, fear to commit to daily dose, no need for ART, not feeling “ready,” too 
much trouble to pick up
16 23.5
In the process of obtaining ART Pending CD4 results, need to schedule appointment, currently attending wellness 
appointment
10 14.7
Other medical issues and difficulties with dosage Only took when pregnant, getting tuberculosis treatment, need alcohol and other drug 
treatment first, did not follow dosage, kept missing dosage
7 10.3
Interpersonal influence Stigma, not disclosed HIV status, boyfriend 5 7.4
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to start ART at a CD4 count of 500 instead of 350 [31]. 
While this change removes a barrier to ART for women 
with CD4 counts between 350 and 500, as of 2016, 
South Africa had not committed sufficient resources to 
implement the recommendation fully. The individual 
and structural barriers to ART reported in this study 
were similar to those reported in previous studies [32] 
that have interfered with achieving the 90-90-90 goals. 
Although the new WHO guidelines recommends provid-
ing ART to everyone regardless of CD4, and the South 
Africa Minister of Health announced support for these 
recommendations, each Province in South Africa will 
have to come to terms with on the ground barriers to 
meeting these needs [33].
Our results could be used to inform future efforts to 
reduce barriers to testing as well as efforts to increase 
treatment access and adherence to achieve the 90-90-90 
target. The independent association between older age 
and HIV infection highlights the importance of offer-
ing prevention interventions, particularly when testing 
younger women. Given some of the staffing constraints 
in health clinics, efforts in Pretoria should focus on the 
inner city because women recruited from the inner city 
were nearly twice as likely to test positive for HIV as 
women recruited from other areas of Pretoria. Clearly, 
women who have been sexually assaulted or experienced 
violence should routinely be offered HIV testing. Offer-
ing substance abuse treatment at the same site where 
ART is offered could increase adherence to ART and 
help address the complex issues of substance use. Free 
transportation to clinics or mobile treatment vans with 
directly observed therapy would help as well. The posi-
tive associations between being engaged in sex work and 
being recruited from the inner city or living in an infor-
mal settlement provide additional support for testing sex 
workers and women in both contexts who use alcohol or 
other drugs.
Limitations
As with all cross-sectional studies, caution should be 
used in drawing causal inferences from associations in 
the multivariable models. Additionally, the study relies 
primarily on self-report data, which is susceptible to 
recall errors and socially desirable responses that may 
reduce the reliability and validity of the results. However, 
the original Risk Behavior Assessment demonstrated 
adequate reliability and validity [34]. Additionally, inter-
viewers underwent intensive training and monitoring 
to minimize eliciting socially desirable responses and 
used calendars to assist participants with recall. Caution 
should be used in extrapolating these findings to other 
populations and to women in other geographic locations.
Conclusions
South Africa faces enormous challenges to achieving the 
UNAIDS 90-90-90 goals for HIV testing, treatment, and 
viral suppression. The country will need to expand the 
scope and increase the frequency of HIV testing among 
sex workers and other women who use alcohol or other 
drugs.
The finding that HIV-positive women recruited 
later in the study were more likely to be on ART than 
women recruited earlier suggests that South Africa is 
making progress in scaling up ART. Nevertheless, only 
44% of women who met the current eligibility criteria 
for ART self-reported they were on it, and that figure 
drops to 30% under the new World Health Organiza-
tion guidelines to treat everyone regardless of their 
CD4 count. South Africa faces enormous challenges 
just to treat 90% of people who are aware of their 
HIV status. The high HIV incidence rates among 
women suggest that for HIV treatment as prevention 
to be successful, STTR efforts will need to be scaled 
up among the men who are infecting them as well as 
among women.
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